December 11 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its CEO Ognyan Donev acquired 43,150 shares in the company through deals priced at 3.10 levs ($1.93/1.59 euro) per share on December 10.